Trial Profile
Effects of vemurafenib and dabrafenib on immune system of patients with melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabrafenib (Primary) ; Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics; Therapeutic Use
- 02 Dec 2015 New trial record